Hemocontrol's Effectiveness on the Reduction of Cardiovascular Long-term EventS
A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 396 participants.
Also called NCT01515878
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose prevention
- Phase
- Phase 4
- Enrolled
- 396 participants
- Registry
-
NCT01515878
-
- Start date
- (registry gives no type)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Canada, France, Italy
- Registry status
- Unknown status
Technical summary
Registry record NCT01515878. Randomized; no masking; primary purpose prevention. Start 2012-02 (registry gives no type); primary completion 2015-03 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Hemocontrol's Effectiveness on the Reduction of Cardiovascular Long-term EventS
- Acronym
- HERACLES
- Condition
- Kidney Failure Chronic
- Condition
- Cardiovascular Diseases
- Intervention (Device)
- Hemocontrol
- Lead sponsor
- IRCCS Azienda Ospedaliero-Universitaria di Bologna
Record details
- Record id
cardio:ct-nct01515878- Content hash
cc851816ec099ade98931f89941df6af67038e4ed1f1607dd412965ea3d51e2b